BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Thyroid cancer

1. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. AXIN2
    [Clinical Outcome] [Diagnosis] [